company background image
300255 logo

Hebei Changshan Biochemical Pharmaceutical SZSE:300255 Stock Report

Last Price

CN¥9.19

Market Cap

CN¥8.4b

7D

-2.6%

1Y

88.3%

Updated

19 Jul, 2024

Data

Company Financials

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

SZSE:300255 Stock Report

Market Cap: CN¥8.4b

300255 Stock Overview

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

300255 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hebei Changshan Biochemical Pharmaceutical
Historical stock prices
Current Share PriceCN¥9.19
52 Week HighCN¥17.98
52 Week LowCN¥4.30
Beta0.14
11 Month Change-7.64%
3 Month Change-5.16%
1 Year Change88.32%
33 Year Change43.15%
5 Year Change42.92%
Change since IPO126.42%

Recent News & Updates

Is Hebei Changshan Biochemical Pharmaceutical (SZSE:300255) Using Too Much Debt?

May 27
Is Hebei Changshan Biochemical Pharmaceutical (SZSE:300255) Using Too Much Debt?

Recent updates

Is Hebei Changshan Biochemical Pharmaceutical (SZSE:300255) Using Too Much Debt?

May 27
Is Hebei Changshan Biochemical Pharmaceutical (SZSE:300255) Using Too Much Debt?

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SZSE:300255) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Apr 15
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SZSE:300255) May Have Run Too Fast Too Soon With Recent 25% Price Plummet

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s (SZSE:300255) 30% Share Price Surge Not Quite Adding Up

Mar 01
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s (SZSE:300255) 30% Share Price Surge Not Quite Adding Up

Shareholder Returns

300255CN PharmaceuticalsCN Market
7D-2.6%1.5%-0.4%
1Y88.3%-13.0%-17.0%

Return vs Industry: 300255 exceeded the CN Pharmaceuticals industry which returned -13% over the past year.

Return vs Market: 300255 exceeded the CN Market which returned -17% over the past year.

Price Volatility

Is 300255's price volatile compared to industry and market?
300255 volatility
300255 Average Weekly Movement8.6%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement5.9%
10% most volatile stocks in CN Market9.1%
10% least volatile stocks in CN Market4.0%

Stable Share Price: 300255's share price has been volatile over the past 3 months.

Volatility Over Time: 300255's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20001,410Xiaodong Gaowww.hbcsbio.com

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin sodium API and injection.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Fundamentals Summary

How do Hebei Changshan Biochemical Pharmaceutical's earnings and revenue compare to its market cap?
300255 fundamental statistics
Market capCN¥8.45b
Earnings (TTM)-CN¥1.31b
Revenue (TTM)CN¥1.20b

7.0x

P/S Ratio

-6.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300255 income statement (TTM)
RevenueCN¥1.20b
Cost of RevenueCN¥1.69b
Gross Profit-CN¥486.89m
Other ExpensesCN¥819.53m
Earnings-CN¥1.31b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 29, 2024

Earnings per share (EPS)-1.42
Gross Margin-40.48%
Net Profit Margin-108.61%
Debt/Equity Ratio117.1%

How did 300255 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.